Literature DB >> 19207427

Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.

Rodrigo A Cormanich1, Mohammad Goodarzi, Matheus P Freitas.   

Abstract

Inhibition of tyrosine kinase enzyme WEE1 is an important step for the treatment of cancer. The bioactivities of a series of WEE1 inhibitors have been previously modeled through comparative molecular field analyses (CoMFA and CoMSIA), but a two-dimensional image-based quantitative structure-activity relationship approach has shown to be highly predictive for other compound classes. This method, called multivariate image analysis applied to quantitative structure-activity relationship, was applied here to derive quantitative structure-activity relationship models. Whilst the well-known bilinear and multilinear partial least squares regressions (PLS and N-PLS, respectively) correlated multivariate image analysis descriptors with the corresponding dependent variables only reasonably well, the use of wavelet and principal component ranking as variable selection methods, together with least-squares support vector machine, improved significantly the prediction statistics. These recently implemented mathematical tools, particularly novel in quantitative structure-activity relationship studies, represent an important advance for the development of more predictive quantitative structure-activity relationship models and, consequently, new drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19207427     DOI: 10.1111/j.1747-0285.2008.00764.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  1 in total

1.  Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma.

Authors:  Meng-Ling Yuan; Pei Li; Zi-Hao Xing; Jin-Ming Di; Hui Liu; An-Kui Yang; Xi-Jun Lin; Qi-Wei Jiang; Yang Yang; Jia-Rong Huang; Kun Wang; Meng-Ning Wei; Yao Li; Jin Ye; Zhi Shi
Journal:  Front Pharmacol       Date:  2018-09-28       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.